Growth Metrics

LifeMD (LFMD) Receivables (2016 - 2026)

LifeMD filings provide 14 years of Receivables readings, the most recent being $9.3 million for Q4 2025.

  • On a quarterly basis, Receivables fell 11.0% to $9.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.3 million, a 11.0% decrease, with the full-year FY2025 number at $9.3 million, down 11.0% from a year prior.
  • Receivables hit $9.3 million in Q4 2025 for LifeMD, up from $9.2 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $10.5 million in Q4 2024 to a low of $73170.0 in Q1 2021.
  • Median Receivables over the past 5 years was $4.0 million (2023), compared with a mean of $4.7 million.
  • Biggest five-year swings in Receivables: crashed 51.86% in 2021 and later soared 2355.24% in 2022.
  • LifeMD's Receivables stood at $980055.0 in 2021, then surged by 189.24% to $2.8 million in 2022, then skyrocketed by 121.03% to $6.3 million in 2023, then skyrocketed by 66.87% to $10.5 million in 2024, then decreased by 11.0% to $9.3 million in 2025.
  • The last three reported values for Receivables were $9.3 million (Q4 2025), $9.2 million (Q3 2025), and $7.3 million (Q2 2025) per Business Quant data.